Subsequently, within the tumour and upon antigen stimulation, these CXCR3+ TEM preferentially differentiate towards PD-1 negative CD8 TEMRA, the proposed effectors of direct anti-tumour cytotoxicity within the TME. Here, CD8A is linked to neoplasm.